Tekla Capital Management LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 89 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$413,000
-64.1%
859,3220.0%0.02%
-63.8%
Q1 2019$1,151,000
+18.5%
859,3220.0%0.05%
+11.9%
Q4 2018$971,000
-59.1%
859,3220.0%0.04%
-51.2%
Q3 2018$2,372,000
-22.7%
859,3220.0%0.09%
-25.9%
Q2 2018$3,068,000
+16.3%
859,3220.0%0.12%
+12.6%
Q1 2018$2,638,000
-51.3%
859,3220.0%0.10%
-50.7%
Q4 2017$5,414,000
-7.9%
859,3220.0%0.21%
-0.5%
Q3 2017$5,878,000
-17.9%
859,322
-14.4%
0.21%
-20.8%
Q2 2017$7,161,000
-22.4%
1,004,3220.0%0.26%
-26.0%
Q1 2017$9,230,000
+1091.0%
1,004,322
+422.2%
0.36%
+984.8%
Q4 2016$775,000
+5.2%
192,3220.0%0.03%
+17.9%
Q3 2016$737,000
-10.9%
192,3220.0%0.03%
-17.6%
Q2 2016$827,000
-7.1%
192,3220.0%0.03%
-10.5%
Q1 2016$890,000
-53.9%
192,3220.0%0.04%
-45.7%
Q4 2015$1,929,000
+34.4%
192,3220.0%0.07%
+34.6%
Q3 2015$1,435,000192,3220.05%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2018
NameSharesValueWeighting ↓
683 Capital Management, LLC 600,000$2,142,0000.14%
Tekla Capital Management LLC 859,322$3,068,0000.12%
DOW CHEMICAL CO /DE/ 65,000$232,0000.08%
Candriam S.C.A. 495,613$1,769,0000.03%
A.R.T. Advisors, LLC 174,335$622,0000.02%
Baker Brothers Advisors 935,000$3,338,0000.02%
FLAGSHIP HARBOR ADVISORS, LLC 29,400$104,0000.02%
Alambic Investment Management, L.P. 17,804$64,0000.02%
Teton Advisors, Inc. 44,000$157,0000.01%
Man Group plc 737,715$2,634,0000.01%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders